Results 161 to 170 of about 35,110 (216)

A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF^V600 wild-type colorectal cancer. [PDF]

Cell Oncol (Dordr), 2021
Georgiou A, Stewart A, Vlachogiannis G, Pickard L, Valeri N, Cunningham D, Whittaker SR, Banerji U.   +7 more
europepmc   +1 more source

LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways. [PDF]

J Cancer, 2022
Yuan HH, Zhang XC, Wei XL, Zhang WJ, Du XX, Huang P, Chen H, Bai L, Zhang HF, Han Y.   +9 more
europepmc   +1 more source

Epacadostat Overcomes Cetuximab Resistance in Colorectal Cancer by Targeting IDO-Mediated Tryptophan Metabolism. [PDF]

Cancer Sci
Zhou Y, Tao Q, Luo C, Chen J, Chen G, Sun J.   +5 more
europepmc   +1 more source

Stress-induced Rab11a-exosomes induce AREG-mediated cetuximab resistance in colorectal cancer

, 2023
Mason JD, Marks E, Fan S, McCormick K, Wilson C, Harris AL, Hamdy FC, Cunningham C, Goberdhan DCI.   +8 more
europepmc   +1 more source

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers. [PDF]

J Cancer Res Clin Oncol, 2022
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Lee KW.   +17 more
europepmc   +1 more source

Single-cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer. [PDF]

Clin Transl Med
Chen S, Tan Z, Wu X, Lin Y, Li X, Cui Y, Man W, Pang F, Li Y, Shi F, Han L, Gou M, Zhou L, Wang Z, Wang Y, Dai G.   +15 more
europepmc   +1 more source

PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance. [PDF]

Head Neck, 2021
Bhola NE, Njatcha C, Hu L, Lee ED, Shiah JV, Kim MO, Johnson DE, Grandis JR.   +7 more
europepmc   +1 more source

Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer. [PDF]

Cancer Cell Int, 2021
Liang L, Liu M, Sun X, Yuan Y, Peng K, Rashid K, Yu Y, Cui Y, Chen Y, Liu T.   +9 more
europepmc   +1 more source

The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance. [PDF]

Cancers (Basel)
Wahoski CC, Singh B.
europepmc   +1 more source

Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma. [PDF]

Cell Mol Life Sci
Zhai P, Tong T, Wang X, Li C, Liu C, Qin X, Li S, Xie F, Mao J, Zhang J, Guo H.   +10 more
europepmc   +1 more source